Abstract
Purpose
This study was conducted to identify the levels of comfort-care provided by trans-arterial chemoembolisation (TACE) nurses and examine the discriminant factors thereof.
Methods
Nurses (n = 146) with experience in caring for TACE patients, participated in this study. The data were collected using an online self-rated questionnaire and analysed with descriptive statistics and discriminant analysis. The discriminating factors included perception of post-embolisation syndrome and symptom interference, caring attitude, barriers to pain and nausea/vomiting management, and supportive care competence.
Results
The participants were classified into three groups, depending on the level of their comfort-care: “low” (n = 27), “moderate” (n = 88), and “high” (n = 31) comfort-care groups. One function significantly discriminated between the low and high comfort-care groups and correctly classified 79.3% of the participants in the cross-validation run. Supportive care competence (0.864), caring attitude (0.685), perception of symptom interference (0.395), perception of post-embolisation syndrome (0.321), and barriers to nausea/vomiting management (− 0.343) were significant discriminant factors of comfort-care.
Conclusion
A low proportion of the participants provided high levels of comfort-care, which was determined by five discriminant factors. The study’s findings imply that the development of supportive care competence, authentic human caring attitude, early detection of patients’ symptoms and symptom interference, and the development of manuals and guidelines for removing barriers for nausea and vomiting are needed to improve the comfort-care of nurses caring for TACE patients.
Similar content being viewed by others
Data availability
Not applicable. The datasets generated during and/or analysed during the current study are not publicly available due to [REASON(S) WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on reasonable request.
Code availability
Not applicable.
References
Chen Z, Xie H, Hu M et al (2020) Recent progress in treatment of hepatocellular carcinoma. Am J Cancer Res 10:2993–3036
Zhang XP, Wang K, Li N et al (2017) Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis. BMC Cancer 17:902
Zhao S, Zhang T, Dou W et al (2020) A comparison of transcatheter arterial chemoembolization used with and without apatinib for intermediate- to advanced-stage hepatocellular carcinoma: a systematic review and meta-analysis. Ann Transl Med 8:542
Blackburn H, West S (2016) Management of postembolization syndrome following hepatic transarterial chemoembolization for primary or metastatic liver cancer. Cancer Nurs 39:E1-e18
Hinrichs JB, Hasdemir DB, Nordlohne M et al (2017) Health-related quality of life in patients with hepatocellular carcinoma treated with initial transarterial chemoembolization. Cardiovasc Intervent Radiol 40:1559–1566
Wensley C, Botti M, McKillop A, Merry AF (2020) Maximising comfort: how do patients describe the care that matters? A two-stage qualitative descriptive study to develop a quality improvement framework for comfort-related care in inpatient settings. BMJ Open 10:e033336
Kolcaba K (2003) Comfort theory and practice: a vision for holistic health care and research. Springer Publishing Company
Toyoda H, Yasuda S, Shiota S et al (2021) Safety, feasibility, and comfort of hepatic angiography and transarterial intervention with radial access for hepatocellular carcinoma. JGH Open 5:1041–1046
Cao W, Li J, Hu C et al (2013) Symptom clusters and symptom interference of HCC patients undergoing TACE: a cross-sectional study in China. Support Care Cancer 21:475–483
Eltawil KM, Berry R, Abdolell M, Molinari M (2012) Quality of life and survival analysis of patients undergoing transarterial chemoembolization for primary hepatic malignancies: a prospective cohort study. HPB (Oxford) 14:341–350
Mason MC, Massarweh NN, Salami A et al (2015) Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma. HPB (Oxford) 17:1137–1144
Williams LA, Bohac C, Hunter S, Cella D (2016) Patient and health care provider perceptions of cancer-related fatigue and pain. Support Care Cancer 24:4357–4363
Karlou C, Papadopoulou C, Papathanassoglou E et al (2018) Nurses’ caring behaviors toward patients undergoing chemotherapy in Greece: a mixed-methods study. Cancer Nurs 41:399–408
Rhodes MK, Morris AH, Lazenby RB (2011) Nursing at its best: competent and caring. Online J Issues Nurs 16:10
Darawad M, Alnajar MK, Abdalrahim MS, El-Aqoul AM (2019) Cancer pain management at oncology units: comparing knowledge, attitudes and perceived barriers between physicians and nurses. J Cancer Educ 34:366–374
Krist AH, Tong ST, Aycock RA, Longo DR (2017) Engaging patients in decision-making and behavior change to promote prevention. Stud Health Technol Inform 240:284–302
Dielenseger P, Börjeson S, Vidall C et al (2019) Evaluation of antiemetic practices for prevention of chemotherapy-induced nausea and vomiting (CINV): results of a European oncology nurse survey. Support Care Cancer 27:4099–4106
Carey ML, Zucca AC, Freund MA et al (2019) Systematic review of barriers and enablers to the delivery of palliative care by primary care practitioners. Palliat Med 33:1131–1145
Dahlin C (2015) Palliative care: delivering comprehensive oncology nursing care. Semin Oncol Nurs 31:327–337
Marzorati C, Riva S, Pravettoni G (2017) Who is a cancer survivor? A systematic review of published definitions. J Cancer Educ 32:228–237
Ahn JK, Kim Y, Choi KH (2019) The psychometric properties and clinical utility of the Korean version of GAD-7 and GAD-2. Front Psychiatry 10:127
Jo M, Koo HY, Cho IY et al (2019) Usefulness of the patient health questionnaire-2 in screening for depression. Kor J Fam Pract 9:336–340
Niglio de Figueiredo M, Krippeit L, Freund J et al (2019) Assessing communication skills in real medical encounters in oncology: development and validation of the comon-coaching rating scales. J Cancer Educ 34:73–81
Lee H, Kim MS, Yoon JA (2011) Role of internal marketing, organizational commitment, and job stress in discerning the turnover intention of Korean nurses. Jpn J Nurs Sci 8:87–94
Brewer BB, Watson J (2015) Evaluation of authentic human caring professional practices. J Nurs Adm 45:622–627
Im S, Cho M, Heo M (2020) Validity and Reliability of the Korean version of the Watson Caritas Patient Score. J Nurs Res 28:e80
Gunnarsdottir S, Donovan HS, Serlin RC et al (2002) Patient-related barriers to pain management: the Barriers Questionnaire II (BQ-II). Pain 99:385–396
Jho HJ, Kim Y, Kong KA et al (2014) Knowledge, practices, and perceived barriers regarding cancer pain management among physicians and nurses in Korea: a nationwide multicenter survey. PLoS One 9:e105900
Sun VC, Borneman T, Ferrell B et al (2007) Overcoming barriers to cancer pain management: an institutional change model. J Pain Symptom Manag 34:359–369
Salsman JM, Grunberg SM, Beaumont JL et al (2012) Communicating about chemotherapy-induced nausea and vomiting: a comparison of patient and provider perspectives. J Natl Compr Canc Netw 10:149–157
Bae EJ (2020) Development of cancer survivor integrated supportive care competence scale for nurses. In Nursing. Busan, Korea: Pukyong National University
Kim BH, Park JW (2018) Epidemiology of liver cancer in South Korea. Clin Mol Hepatol 24:1–9
Nurhesti POY, Adiputra IN (2020) Assessment and management of cancer-related fatigue: Health care providers’ perceptions. Enferm Clin 30(Suppl 7):86–89
Buss MK, Rock LK, McCarthy EP (2017) Understanding palliative care and hospice: a review for primary care providers. Mayo Clin Proc 92:280–286
Reeve BB, Wyrwich KW, Wu AW et al (2013) ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res 22:1889–1905
Wu XD, Qin HY, Zhang JE et al (2015) The prevalence and correlates of symptom distress and quality of life in Chinese oesophageal cancer patients undergoing chemotherapy after radical oesophagectomy. Eur J Oncol Nurs 19:502–508
Kwekkeboom KL, Tostrud L, Costanzo E et al (2018) The role of inflammation in the pain, fatigue, and sleep disturbance symptom cluster in advanced cancer. J Pain Symptom Manag 55:1286–1295
Gjoreski A, Jovanoska I, Risteski F et al (2021) Single-center randomized trial comparing conventional chemoembolization versus doxorubicin-loaded polyethylene glycol microspheres for early- and intermediate-stage hepatocellular carcinoma. Eur J Cancer Prev 30(3):258–266
Jung SN, Seon JI, Kim KS (2017) The factors of pain and pain management after transarterial chemoembolization in patients with hepatocellular carcinoma. AON 17:107–115
Klafke N, Mahler C, von Hagens C et al (2019) The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial. Cancer Med 8:3666–3676
Kim HS, Jang H-Y, Yi M, Seo HY (2017) Cancer survivorship care among oncology nurses in Korea. AON 17:124–132
Weaver SJ, Jacobsen PB (2018) Cancer care coordination: opportunities for healthcare delivery research. Transl Behav Med 8:503–508
Pratt H, Moroney T, Middleton R (2021) The influence of engaging authentically on nurse-patient relationships: a scoping review. Nurs Inq 28:e12388
Shim EJ, Park JE, Yi M et al (2016) Tailoring communications to the evolving needs of patients throughout the cancer care trajectory: a qualitative exploration with breast cancer patients. BMC Womens Health 16:65
Lee JR (2019) Oh PJ [A Structural Model for Chemotherapy Related Cognitive Impairment and Quality of Life in Breast Cancer Patients]. J Korean Acad Nurs 49:375–385
Lannie A (2021) Three types of emotional engagement: caring for the older person with cancer in two ward settings. Eur J Oncol Nurs 54:102012
Kuwaki K, Nouso K, Miyashita M et al (2019) The efficacy and safety of steroids for preventing postembolization syndrome after transcatheter arterial chemoembolization of hepatocellular carcinoma. Acta Med Okayama 73:333–339
White N, Reid F, Harris A et al (2016) A systematic review of predictions of survival in palliative care: how accurate are clinicians and who are the experts? PLoS One 11:e0161407
Lu H, Zheng C, Liang B, Xiong B (2021) Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis. BMC Cancer 21:513
Makhlouf SM, Pini S, Ahmed S, Bennett MI (2020) Managing pain in people with cancer—a systematic review of the attitudes and knowledge of professionals, patients, caregivers and public. J Cancer Educ 35:214–240
Chang L, Wang W, Jiang N et al (2020) Dexamethasone prevents TACE-induced adverse events: a meta-analysis. Medicine (Baltimore) 99:e23191
Yang H, Seon J, Sung PS et al (2017) Dexamethasone prophylaxis to alleviate postembolization syndrome after transarterial chemoembolization for hepatocellular carcinoma: a randomized, double-blinded, placebo-controlled study. J Vasc Interv Radiol 28:1503-1511.e1502
Tabachnick BG, Fidell LS (2013) Using multivariate statistics. Pearson, Boston
Kacaroğlu VA (2020) The effect of training given to hemodialysis patients according to the comfort theory. Clin Nurse Spec 34:30–37
Langbecker D, Ekberg S, Yates P et al (2016) What are the barriers of quality survivorship care for haematology cancer patients? Qualitative insights from cancer nurses. J Cancer Surviv 10:122–130
Funding
This work was supported by the National Research Foundation of Korea (NRF) funded by the Korea government Ministry of Science and ICT (MSIT) (No. 2020R1A2C1010378).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Myoung Soo Kim. The first draft of the manuscript was written by Ju-Yeon Uhm, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval
This study was conducted after review and approval by the institutional review board (IRB No:1041386–202009-HR-53–01). On the survey’s first web-page, the purpose of the study, research methods, voluntary participation, assurance of anonymity, and the possibility of withdrawal from participation were explained to participants in detail. Informed consent was then obtained online from participants prior to the initiation of the survey.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kim, M.S., Uhm, JY. Impact of discriminant factors on the comfort-care of nurses caring for trans-arterial chemoembolisation patients. Support Care Cancer 30, 7773–7781 (2022). https://doi.org/10.1007/s00520-022-07221-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-022-07221-0